Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
The Ewha Medical Journal ; : 50-54, 2017.
Article Dans Anglais | WPRIM | ID: wpr-95356

Résumé

Constipation is a prevalent, often chronic, gastrointestinal motility disorder. Bisacodyl, a stimulant laxative, is widely used to treat constipation in adults and children. This drug is usually safe, but it has some side effects including diarrhea, abdominal pain, colitis, and proctitis. There have been reports that rectal administration of bisacodyl could cause injury to the rectal mucosa by mechanical and chemical mechanisms. However, there has been no report of severe proctitis with rectal ulcers in patients taking oral bisacodyl. In this report, we describe the case of an 80-year-old woman with severe rectal ulcers and proctitis after taking oral bisacodyl for several days, and review the literature.


Sujets)
Adulte , Sujet âgé de 80 ans ou plus , Enfant , Femelle , Humains , Douleur abdominale , Administration par voie rectale , Bisacodyl , Colite , Constipation , Diarrhée , Motilité gastrointestinale , Muqueuse , Rectite , Rectum , Ulcère
2.
Journal of Korean Diabetes ; : 178-184, 2014.
Article Dans Coréen | WPRIM | ID: wpr-726964

Résumé

Atypical antipsychotics, which have better efficacy and fewer side effects compared to first-generation antipsychotics, are being used increasingly for the treatment of schizophrenia. However, adverse events such as weight gain, diabetes mellitus and abnormal lipid profile have been reported in patients treated with these agents. Diabetic ketoacidosis (DKA) is a rare side effect of atypical antipsychotics, but deserves attention due to its severity. Although various atypical antipsychotics have been reported as causing DKA, there have been no reports showing an association with DKA and paliperidone, which is a recently developed antipsychotic agent. Here, we report two cases of DKA in patients with paliperidone therapy. Both cases had no history of diabetes before use of paliperidone, and DKA was manifested within 2 years of starting paliperidone therapy. Like other atypical antipsychotics, use of paliperidone warrants monitoring for metabolic derangements including DKA.


Sujets)
Humains , Neuroleptiques , Diabète , Acidocétose diabétique , Schizophrénie , Prise de poids
SÉLECTION CITATIONS
Détails de la recherche